Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by HuntNGatheron Sep 24, 2010 1:53pm
551 Views
Post# 17489655

Edmonton?

Edmonton?
beststocks1<strong>Reputation</strong>: A calculation of the weighted quality, performance, and participation scores on a scale of one to ten.</p>")">3
9/20/2010 3:45:30 PM | | 241 reads | Post #28613736
In my opinion with a price range between 6 and 6 1/2 cents lately, I loaded up on stock at 6 1/2. On the 23th of this month the scientists for Stem Cell are having a public meeting at McEwen university in Edmonton to discuss public, the research findings. After this time, with good news on the table the stock will move upwards. An investment today in SSS, may reap rewards after the 23th. I am going wait and see on the news conference
Bullboard Posts